CytoMed (GDTC) 10% Owner Choo Chee Kong Buys 200,000 Shares

What Happened
Choo Chee Kong, listed as a 10% owner of CytoMed Therapeutics Ltd (GDTC), made two purchases of the company's stock: 100,000 shares on 2026-07-14 at $1.50 each ($150,000) and 100,000 shares on 2026-07-20 at $1.50 each ($150,000), for a combined 200,000 shares purchased for $300,000. The transactions are reported as purchases (transaction code P).

Key Details

• Transaction dates and prices: 2026-07-14 — 100,000 shares @ $1.50 ($150,000); 2026-07-20 — 100,000 shares @ $1.50 ($150,000).
• Total purchased: 200,000 shares for $300,000.
• Filing: Form 4 covering these trades was filed 2026-07-24. The filing is marked late (transactionTimeliness = 'L').
• Shares owned after transaction: not specified in the information provided on the filing.
• Method: Reported as open market or private purchase (P). No 10b5-1 plan, tax withholding, or other footnotes were provided in the summary data.

Context
Purchases by a 10% owner are direct insider buys but may reflect large-investor activity rather than routine executive compensation moves. The late filing reduces the timeliness of this disclosure (insiders are generally required to file Form 4 within two business days), which can affect how quickly investors see and react to the trades. This summary is factual and does not speculate on the insider's motives.